Today’s decision by the Competition & Markets Authority (CMA), allowing the NHS hospital trusts in Bournemouth and Poole to merge, is a significant milestone. The CMA has overturned the Competition Commission’s (CC’s) prohibition of this merger, and it may also be the CMA’s last review of an NHS trust merger where the focus is on…
Guides, White Papers & Research
Buy-and-Build Strategies: Managing the risk of UK Competition and Markets Authority intervention
This paper draws on our experience as former competition regulators, and our research on buy-and-builds, to identify opportunities that can mitigate the risk of CMA intervention for these platforms.
It contains practical advice around:
- The likelihood of deals being called-in by the CMA
- Influencing the CMA’s view of a market
- How to best engage with the CMA
- Drivers of CMA review costs
Fill in your details to receive your copy:
We will never share your details with anyone.